Pmd65 - Economic Value of Narrow Band Imaging Versus White Light Endoscopy for the Management of Non-Muscle Invasive Bladder Cancer: Cost-Consequence Model

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Contemporary Cost-Consequence Analysis of Blue Light Cystoscopy With Hexaminolevulinate in Non-Muscle-Invasive Bladder Cancer

Canadian Urological Association Journal
Urology
2017English

Diagnostic Accuracy of Photodynamic Diagnosis With 5-Aminolevulinic Acid, Hexaminolevulinate and Narrow Band Imaging for Non-Muscle Invasive Bladder Cancer

Journal of Cancer
Oncology
2020English

Photodynamic Versus White Light-Guided Treatment of Non-Muscle Invasive Bladder Cancer: A Study Protocol for a Randomised Trial of Clinical and Cost-Effectiveness

BMJ Open
Medicine
2019English

Comparison of the Diagnostic Efficacy of White Light Endoscopy and Magnifying Endoscopy With Narrow Band Imaging for Early Gastric Cancer: A Meta-Analysis

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2015English

The Usefulness of White Light Endoscopy, Narrow Band Imaging, and Magnification for the Optimization of Diagnosis in Barrett’s Esophagus

Acta Medica Marisiensis
2014English

Contemporary Management of Muscle-Invasive Bladder Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2012English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Prediction Tools in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy